Loading stock data…
CLBT
$13.35+0.35 (+2.69%)
Market ClosedLast close May 1
Cellebrite DI Ltd.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cellebrite DI Ltd. in the Technology sector is trading at $13.35. The stock is currently 35% below its 52-week high of $20.45, remaining 16.4% below its 200-day moving average. Technical signals show overbought RSI of 75 and bullish MACD crossover, explaining why CLBT maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 75) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
AAPLMSFTGOOGL
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$13.35
Potential Downside
47.7%
Whystock Fair Value$6.98
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, ext...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.14B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
40.63
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.27
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
16.17%
Volume
Today's trading volume
3.52M
Recent News
Five9 (FIVN) Q1 Earnings and Revenues Top Estimates
Five9 (FIVN) delivered earnings and revenue surprises of +10.61% and +1.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now?
Is CLBT a good stock to buy? We came across a bullish thesis on Cellebrite DI Ltd. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on CLBT. Cellebrite DI Ltd.’s share was trading at $13.38 as of April 20th. CLBT’s trailing and forward P/E were 43.16 and 35.71 respectively according to Yahoo Finance. Cellebrite […]
Assessing Cellebrite DI (CLBT) Valuation After A Steep Multi‑Period Share Price Pullback
Recent performance snapshot Cellebrite DI (CLBT) has drawn investor attention after a weak price trend. The stock has shown a 0.2% decline over the past day, a 3.6% decline over the past week, and a 23.3% decline over the past 3 months. See our latest analysis for Cellebrite DI. Zooming out, the recent share price weakness builds on a longer stretch of pressure, with a 28.8% year to date share price decline and a 35.3% 1 year total shareholder return decline. This contrasts with a very large...
Cellebrite DI Spring 2026 Release Tests Undervalued Stock Story
Cellebrite DI (NasdaqGS:CLBT) has rolled out its Spring 2026 Release. The update broadens support for a wider range of iOS and Android devices, including iPhone 17 and iOS 26. The release also adds integration with Corellium on Google Cloud for digital investigations. Cellebrite DI, trading at $12.7, is updating its product suite at a time when its share price has seen a 28.8% decline year to date and a 35.3% decline over the past year. Over a 3 year period, the stock shows a 134.8% gain,...
Here is What Makes Cellebrite DI (CLBT) a Top Cybersecurity Pick
Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the 10 best cybersecurity stocks to invest in according to analysts. On March 31, Cellebrite DI Ltd. (NASDAQ:CLBT) announced the launch of the Spring 2026 Release, providing access to a great number of iOS and Android devices and operating systems. The release features support for iPhone 17 and […]